[Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom].
D'Arcy
P F
PF
D020909:Acarbose; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D002316:Cardiotonic Agents / Q000009:adverse effects; D020117:Cisapride / Q000009:adverse effects; D000075202:Contraindications; D004077:Digoxin / Q000009:adverse effects; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D000431:Ethanol / Q000009:adverse effects; D005765:Gastrointestinal Agents / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D015474:Isotretinoin / Q000009:adverse effects; D007641:Keratolytic Agents / Q000009:adverse effects; D004364:Pharmaceutical Preparations; D013792:Thalidomide / Q000009:adverse effects; D014312:Trisaccharides / Q000009:adverse effects; D006113:United Kingdom
D018712:Analgesics, Non-Narcotic; D000928:Antidepressive Agents; D002316:Cardiotonic Agents; D005765:Gastrointestinal Agents; D007004:Hypoglycemic Agents; D007641:Keratolytic Agents; D004364:Pharmaceutical Preparations; D014312:Trisaccharides; D000431:Ethanol; D013792:Thalidomide; D004077:Digoxin; D015474:Isotretinoin; D020909:Acarbose; D020117:Cisapride
Réactions et interactions des médicaments. Mise en garde du Committee on Safety of Medicines du Royaume Uni (CSM).